Chemoinformaics analysis of 8ALPHA-3-COPAEN-8-OL
Molecular Weight | 220.356 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
Exact Molecular Weight | 220.183 | nRing | 4 |
Solubility: LogS | -3.033 | nHRing | 0 |
Solubility: LogP | 3.467 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.673 |
Synth | 5.639 |
Natural Product Likeliness | 3.265 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.01 |
HIA | 0.01 |
CACO-2 | -4.378 |
MDCK | 0.0000332 |
BBB | 0.764 |
PPB | 0.933785 |
VDSS | 1.504 |
FU | 0.0482755 |
CYP1A2-inh | 0.114 |
CYP1A2-sub | 0.555 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.899 |
CYP2c9-inh | 0.086 |
CYP2c9-sub | 0.419 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.421 |
CYP3a4-inh | 0.071 |
CYP3a4-sub | 0.356 |
CL | 19.384 |
T12 | 0.112 |
hERG | 0.025 |
Ames | 0.013 |
ROA | 0.549 |
SkinSen | 0.046 |
Carcinogencity | 0.053 |
EI | 0.015 |
Respiratory | 0.793 |
NR-Aromatase | 0.002 |
Antiviral | Yes |
Prediction | 0.908264 |